These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 11134398)

  • 1. Multiple system atrophy/progressive supranuclear palsy: alpha-Synuclein, synphilin, tau, and APOE.
    Morris HR; Vaughan JR; Datta SR; Bandopadhyay R; Rohan De Silva HA; Schrag A; Cairns NJ; Burn D; Nath U; Lantos PL; Daniel S; Lees AJ; Quinn NP; Wood NW
    Neurology; 2000 Dec; 55(12):1918-20. PubMed ID: 11134398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive impairment in progressive supranuclear palsy is associated with tau burden.
    Koga S; Parks A; Kasanuki K; Sanchez-Contreras M; Baker MC; Josephs KA; Ahlskog JE; Uitti RJ; Graff-Radford N; van Gerpen JA; Wszolek ZK; Rademakers R; Dickson DW
    Mov Disord; 2017 Dec; 32(12):1772-1779. PubMed ID: 29082658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-alpha synuclein and anti-tau immunotherapies: Can a cocktail approach work?
    Del Giudice KP; Cosgaya M; Zaro I; Ravasi V; Santacruz P; Painous C; Fernández M; Cámara A; Compta Y
    Parkinsonism Relat Disord; 2024 May; 122():106080. PubMed ID: 38508903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E Gene in α-Synucleinopathies: A Narrative Review.
    Liampas I; Kyriakoulopoulou P; Siokas V; Tsiamaki E; Stamati P; Kefalopoulou Z; Chroni E; Dardiotis E
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetic basis of multiple system atrophy.
    Tseng FS; Foo JQX; Mai AS; Tan EK
    J Transl Med; 2023 Feb; 21(1):104. PubMed ID: 36765380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau and MAPT genetics in tauopathies and synucleinopathies.
    Leveille E; Ross OA; Gan-Or Z
    Parkinsonism Relat Disord; 2021 Sep; 90():142-154. PubMed ID: 34593302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOE2: protective mechanism and therapeutic implications for Alzheimer's disease.
    Li Z; Shue F; Zhao N; Shinohara M; Bu G
    Mol Neurodegener; 2020 Nov; 15(1):63. PubMed ID: 33148290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Quarter Century of APOE and Alzheimer's Disease: Progress to Date and the Path Forward.
    Belloy ME; Napolioni V; Greicius MD
    Neuron; 2019 Mar; 101(5):820-838. PubMed ID: 30844401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of APOE in atypical parkinsonism syndromes.
    Sabir MS; Blauwendraat C; Ahmed S; Serrano GE; Beach TG; Perkins M; Rice AC; Masliah E; Morris CM; Pihlstrom L; Pantelyat A; Resnick SM; Cookson MR; Hernandez DG; Albert M; Dawson TM; Rosenthal LS; Houlden H; Pletnikova O; Troncoso J; Scholz SW
    Neurobiol Dis; 2019 Jul; 127():142-146. PubMed ID: 30798004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple system atrophy and apolipoprotein E.
    Ogaki K; Martens YA; Heckman MG; Koga S; Labbé C; Lorenzo-Betancor O; Wernick AI; Walton RL; Soto AI; Vargas ER; Nielsen HM; Fujioka S; Kanekiyo T; Uitti RJ; van Gerpen JA; Cheshire WP; Wszolek ZK; Low PA; Singer W; Dickson DW; Bu G; Ross OA
    Mov Disord; 2018 Apr; 33(4):647-650. PubMed ID: 29442376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple system atrophy: the application of genetics in understanding etiology.
    Federoff M; Schottlaender LV; Houlden H; Singleton A
    Clin Auton Res; 2015 Feb; 25(1):19-36. PubMed ID: 25687905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-synuclein biology in Lewy body diseases.
    Kim WS; Kågedal K; Halliday GM
    Alzheimers Res Ther; 2014; 6(5):73. PubMed ID: 25580161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple system atrophy: genetic or epigenetic?
    Sturm E; Stefanova N
    Exp Neurobiol; 2014 Dec; 23(4):277-91. PubMed ID: 25548529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy.
    Don AS; Hsiao JH; Bleasel JM; Couttas TA; Halliday GM; Kim WS
    Acta Neuropathol Commun; 2014 Oct; 2():150. PubMed ID: 25358962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants in diseases of the extrapyramidal system.
    Oczkowska A; Kozubski W; Lianeri M; Dorszewska J
    Curr Genomics; 2014 Feb; 15(1):18-27. PubMed ID: 24653660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copy number loss of (src homology 2 domain containing)-transforming protein 2 (SHC2) gene: discordant loss in monozygotic twins and frequent loss in patients with multiple system atrophy.
    Sasaki H; Emi M; Iijima H; Ito N; Sato H; Yabe I; Kato T; Utsumi J; Matsubara K
    Mol Brain; 2011 Jun; 4():24. PubMed ID: 21658278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic players in multiple system atrophy: unfolding the nature of the beast.
    Stemberger S; Scholz SW; Singleton AB; Wenning GK
    Neurobiol Aging; 2011 Oct; 32(10):1924.e5-14. PubMed ID: 21601954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Function and comorbidities of apolipoprotein e in Alzheimer's disease.
    Leduc V; Domenger D; De Beaumont L; Lalonde D; Bélanger-Jasmin S; Poirier J
    Int J Alzheimers Dis; 2011 Apr; 2011():974361. PubMed ID: 21559182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy.
    Al-Chalabi A; Dürr A; Wood NW; Parkinson MH; Camuzat A; Hulot JS; Morrison KE; Renton A; Sussmuth SD; Landwehrmeyer BG; Ludolph A; Agid Y; Brice A; Leigh PN; Bensimon G;
    PLoS One; 2009 Sep; 4(9):e7114. PubMed ID: 19771175
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.